Valeant said it expects to report stronger-than-expected results for its third quarter and continued its push to bring Botox maker Allergan to the negotiating table as their takeover battle enters its fifth month.
from WSJ.com: US Business http://ift.tt/1B6TZBb
via IFTTT
from WSJ.com: US Business http://ift.tt/1B6TZBb
via IFTTT
No comments:
Post a Comment